✦ LIBER ✦

Carboplatin (C) and docetaxel (D) in previously untreated advanced non-small cell lung carcinoma (NSCLC): A multicenter phase II trial

✍ Scribed by Jahanzeb, M; Sarna, G; Hirsch, R; Radice, P; Koletsky, A; Martinez, M; Kruglyak, E; Wolin, E; Comacho, E; Kronish, L; Byrne, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of docetaxel and carbop

✍ Akira Shoji; Takashi Ogura; Kaneo Suzuki; Hiroshi Takahashi; Kenichi Takahashi; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 67 KB

Phase I/II trial of weekly Docetaxel and

✍ Kasturi, V; O'Connell, T; Gordon, J; Walsh, W; Horner, R; Strauss, G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase II trial of weekly docetaxel and g

✍ Park, Se Hoon; Hong, Junshik; Kim, Young Saing; Kim, Yujin; Kyung, Sun Young; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase II trial of docetaxel in previousl

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase II Trial of Bevacizumab plus Pemet

✍ C. Dalsania; A. Hageboutros; E. Harris; K. Krieger; C. Vora; J.P. Stevenson 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Carboplatin and docetaxel in advanced no

✍ Sakkaraiappan Ramalingam; TracyW. Dobbs; AviI. Einzig; Slawomir Wojtowicz-Praga; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 181 KB